FENC
Fennec Pharmaceuticals Inc.
NASDAQ · USHealthcareBiotechnology
$9.90-5.71%
Price as of Jul 20, 2026
FENC capital
Fennec Pharmaceuticals Inc. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.07x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 6.02x
Liquidity & coverage
- Current ratio
- 6.98x
- Quick ratio
- 6.78x
- Cash ratio
- 4.19x
- Interest coverage
- -3.71x
- EBITDA / interest
- -4.40x
- Working capital
- $57.3M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.